Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Selcia Limited
Selcia Limited
Activities:
Research & Development
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Media
Selcia joins Eurofins Group
Selcia, specialist provider of custom radiolabelling and integrated drug discovery services, announced it has been acquired by Eurofins Scientific, a global specialist in analytical testing and pharma discovery services
Research & Development
Selcia publishes strategy for structural simplification of natural products
The paper outlines a technique to generate synthetically tractable cyclophilin inhibitors for the treatment of hepatitis C
Ingredients
Selcia opens new dedicated 14C GMP API facility
To help the firm meet increasing demand for 14C radiolabelled compounds
Research & Development
Selcia and Cantab announce drug discovery collaboration
To develop improved antibiotics for multi-drug resistant Gram-negative bacterial infections
Ingredients
Selcia granted patent for drug discovery platform
The patent covers technology underpinning the UK-based company’s CEfrag drug screening service
Research & Development
Selcia exploits in-house IP with demerger
Forms Mitopharm and Selcia Pharma to protect IP while attracting external investment
Research & Development
Convergence Pharmaceuticals and Selcia in r&d collaboration
Aim is to identify and develop high quality candidate molecules for the treatment of chronic pain
Subscribe now